Literature DB >> 28085999

Review: Immune-Related Adverse Events With Use of Checkpoint Inhibitors for Immunotherapy of Cancer.

Maria E Suarez-Almazor1, Sang T Kim1, Noha Abdel-Wahab2, Adi Diab1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28085999     DOI： 10.1002/art.40043

Source DB:  PubMed          Journal:  Arthritis Rheumatol        ISSN： 2326-5191            Impact factor:   10.995


× No keyword cloud information.
  37 in total

Review 1.  Rheumatology in Egypt: back to the future.

Authors:  Tamer A Gheita; Nahla N Eesa
Journal:  Rheumatol Int       Date:  2018-11-07       Impact factor: 2.631

Review 2.  Ubiquitin Ligases in Cancer Immunotherapy - Balancing Antitumor and Autoimmunity.

Authors:  Yu Fujita; Roberto Tinoco; Yan Li; Daniela Senft; Ze'ev A Ronai
Journal:  Trends Mol Med       Date:  2019-03-18       Impact factor: 11.951

Review 3.  [Adverse effects of immunotherapy : Clinical aspects, radiological and nuclear medicine results].

Authors:  G Widmann; V A Nguyen; J Plaickner; W Jaschke
Journal:  Radiologe       Date:  2017-10       Impact factor: 0.635

Review 4.  Systemic Vasculitis Associated With Immune Check Point Inhibition: Analysis and Review.

Authors:  Teresa M Crout; Day S Lennep; Shweta Kishore; Vikas Majithia
Journal:  Curr Rheumatol Rep       Date:  2019-05-21       Impact factor: 4.592

5.  Blockade of Treg Cell Differentiation and Function by the Interleukin-21-Mechanistic Target of Rapamycin Axis Via Suppression of Autophagy in Patients With Systemic Lupus Erythematosus.

Authors:  Hiroshi Kato; Andras Perl
Journal:  Arthritis Rheumatol       Date:  2018-01-30       Impact factor: 10.995

6.  SEOM clinical guideline for the management of immune-related adverse events in patients treated with immune checkpoint inhibitors (2019).

Authors:  M Majem; E García-Martínez; M Martinez; E Muñoz-Couselo; D Rodriguez-Abreu; R Alvarez; A Arance; A Berrocal; L de la Cruz-Merino; J A Lopez-Martin
Journal:  Clin Transl Oncol       Date:  2020-01-28       Impact factor: 3.405

Review 7.  Immune checkpoint inhibitor-induced inflammatory arthritis as a model of autoimmune arthritis.

Authors:  Laura C Cappelli; Mekha A Thomas; Clifton O Bingham; Ami A Shah; Erika Darrah
Journal:  Immunol Rev       Date:  2020-01-13       Impact factor: 12.988

8.  Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline.

Authors:  Julie R Brahmer; Christina Lacchetti; Bryan J Schneider; Michael B Atkins; Kelly J Brassil; Jeffrey M Caterino; Ian Chau; Marc S Ernstoff; Jennifer M Gardner; Pamela Ginex; Sigrun Hallmeyer; Jennifer Holter Chakrabarty; Natasha B Leighl; Jennifer S Mammen; David F McDermott; Aung Naing; Loretta J Nastoupil; Tanyanika Phillips; Laura D Porter; Igor Puzanov; Cristina A Reichner; Bianca D Santomasso; Carole Seigel; Alexander Spira; Maria E Suarez-Almazor; Yinghong Wang; Jeffrey S Weber; Jedd D Wolchok; John A Thompson
Journal:  J Clin Oncol       Date:  2018-02-14       Impact factor: 44.544

Review 9.  Isolated testicular vasculitis due to immune checkpoint inhibitor.

Authors:  Rebecca Weiner; Britt Hanson; Jamaal Rehman; Bob Sun
Journal:  Eur J Rheumatol       Date:  2019-11-25

10.  Inhibitory Receptor Expression on T Cells as a Marker of Disease Activity and Target to Regulate Effector Cellular Responses in Rheumatoid Arthritis.

Authors:  Luisina I Onofrio; Estefania R Zacca; Paola Ferrero; Cristina Acosta; Eduardo Mussano; Laura Onetti; Isaac Cadile; M Victoria Gazzoni; Raúl Jurado; Jimena Tosello Boari; Maria C Ramello; Carolina L Montes; Adriana Gruppi; Eva V Acosta Rodríguez
Journal:  Arthritis Rheumatol       Date:  2018-08-06       Impact factor: 10.995
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.